Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
AbstractNumerous studies have compared outcomes of liver resection (LR) of patients with non-alcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) to those of patients with non-NAFLD-related HCC. However, results have been inconsistent. We aim to clarify this issue. We enrolled 801 patients with hepatitis B virus (HBV)-related HCC, 433 patients with hepatitis C virus (HCV)-related HCC, and 128 patients with NAFLD-related HCC undergoing LR. Overall survival (OS) and disease-free survival (DFS) of patients with different etiologies of chronic liver disease was compared using the Kaplan –Meier estimat...
Source: Updates in Surgery - April 7, 2024 Category: Surgery Source Type: research
